Literature DB >> 17502038

Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift?

Takashi Yamamura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17502038     DOI： 10.1007/s11926-007-0001-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  20 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

6.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

Authors:  David Yen; Jeanne Cheung; Heleen Scheerens; Frédérique Poulet; Terrill McClanahan; Brent McKenzie; Melanie A Kleinschek; Alex Owyang; Jeanine Mattson; Wendy Blumenschein; Erin Murphy; Manjiri Sathe; Daniel J Cua; Robert A Kastelein; Donna Rennick
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

Authors:  Yi Chen; Claire L Langrish; Brent McKenzie; Barbara Joyce-Shaikh; Jason S Stumhofer; Terrill McClanahan; Wendy Blumenschein; Tatyana Churakovsa; Justin Low; Leonard Presta; Christopher A Hunter; Robert A Kastelein; Daniel J Cua
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.

Authors:  Takaaki Ishizu; Manabu Osoegawa; Feng-Jun Mei; Hitoshi Kikuchi; Masahito Tanaka; Yuka Takakura; Motozumi Minohara; Hiroyuki Murai; Futoshi Mihara; Takayuki Taniwaki; Jun-ichi Kira
Journal:  Brain       Date:  2005-03-02       Impact factor: 13.501

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

Review 10.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527
View more
  2 in total

1.  NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora.

Authors:  Hiroaki Yokote; Sachiko Miyake; J Ludovic Croxford; Shinji Oki; Hidehiro Mizusawa; Takashi Yamamura
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

2.  CD39 and CD161 modulate Th17 responses in Crohn's disease.

Authors:  Aiping Bai; Alan Moss; Efi Kokkotou; Anny Usheva; Xiaofeng Sun; Adam Cheifetz; Yi Zheng; Maria Serena Longhi; Wenda Gao; Yan Wu; Simon C Robson
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.